INDUSTRY SYMPOSIUM 7

 

13:15 - 15:15    G104-105

 

Optimal Therapy of SHPT: Is it Possible?
 
Chairs: Marc Vervloet, Amsterdam, The Netherlands
             Armando L. Negri, Buenos Aires, Argentina
 
Lessons learned from VITAL, IMPACT and PRIMO
Daniel Coyne, St. Louis, USA
  
Measuring PTH: How SHPT treatment is affected by the assay used and type of PTH measured
Berthold Hocher, Potsdam, Germany
  
When VitD treatment fails; what is next?
Mario Cozzolino, Milan, Italy
  
Question and answer
 
Organised by ABBVIE

 

back to the timetable